Home Medicine Cryoglobulin pre-analysis over the weekend
Article Open Access

Cryoglobulin pre-analysis over the weekend

  • Corrie de Kat Angelino , Chantal P. Rovers and Joannes F.M. Jacobs EMAIL logo
Published/Copyright: July 8, 2025

To the Editor,

Maintenance of blood samples at 37 °C during all pre-analytical phases is crucial for optimal cryoglobulin detection. Because the pre-analytical cryoglobulin workflow is laborious, time-consuming and requires specialized equipment, most hospitals do not accept blood samples for cryoglobulin analysis during weekends or bank holidays. In this validation study we demonstrated that during pre-analytical cryoglobulin workup the clotting time can be extended up to three days when blood samples are stored at 37 °C, allowing further cryoglobulin analysis during office hours.

Cryoglobulins consist of serum immunoglobulins that precipitate below 37 °C and resolubilize upon warming. Cryoglobulinemia generally involves small-to-medium vessel vasculitis caused by cryoglobulin-containing immune complexes. Cryoglobulinemia can cause a broad variety of symptoms including purpura, livedo reticularis, ischemia of extremities, arthralgia, fatigue, peripheral neuropathy, abdominal pain and glomerulonephritis. Treatment options are primarily directed towards identification and management of the underlying disease [1]. Fifty years ago Brouet et al. proposed a classification of cryoglobulins [2], which is still widely used because it is indicative for the identification of the disorder that underlies the cryoglobulinemia. Type I cryoglobulins are monoclonal immunoglobulins. Type II cryoglobulins are composed of both a monoclonal and polyclonal immunoglobulins. Type III cryoglobulins are composed of exclusively polyclonal immunoglobulins [3].

The laboratory work-up of cryoglobulin diagnostics involves three phases [4]. In the pre-analytical phase it is crucial that the blood remains at 37 °C throughout all steps from drawing blood, transport, coagulation and the centrifuge step to separate serum. In the second phase the serum is incubated for at least three days (preferably seven) at 4 °C to allow cryoglobulins to precipitate. The formed cryoglobulin precipitate is washed in saline (0.9 % NaCl), resolubilized at 37 °C and quantified. Finally, the washed cryoprecipitate is typed using immunofixation electrophoresis. The most critical factor affecting cryoglobulin testing is that all pre-analytical steps are completed at 37 °C [5], [6]. This unique pre-analytical workflow requires amongst others specialized equipment such as a pre-heated centrifuge which is not easily implemented in a 24/7 diagnostic service. This is one of the reasons why most hospitals can’t accept blood samples for cryoglobulin analysis during weekends or bank holidays.

It is well established in literature that collected blood for cryoglobulin analysis should coagulate at 37 °C for at least 1 h prior to separation of the serum-fraction by centrifugation [3], [5], [7]. It has never been studied whether the coagulation time at 37 °C can be extended with a couple of days. This would be valuable information in case a medical center is willing to accept cryoglobulin blood samples any day and hour of the week and postpone further pre-analytical workup to regular office hours. In this study we therefore validated whether blood samples for routine cryoglobulin testing could be stored and clotted at 37 °C for 72 h prior to further serum processing.

For this method comparison two different pre-analytical workflows were compared: ‘routine’ cryoglobulin analysis vs. our adapted ‘3-day-protocol’. For routine cryoglobulin analysis we have adopted the protocol previously described by Sargur et al. [7]. Briefly, after collection of serum blood-tube without separating gel it is directly transported in a preheated container to the laboratory at 37 °C. The sample is allowed to clot for 1–2 h at 37 °C and centrifuged 1,500 g for 15 min at 37 °C. At least 4 mL serum is separated and stored for at least three days at 4 °C. After centrifugation at 1,500 g for 15 min at 4 °C, visual inspection is performed to identify cryoprecipitate formation. Positive samples are washed three times at 1,500 g for 15 min with saline (0.9 % NaCl) at 4 °C. The washed cryoprecipitate is dissolved in 1 mL saline at 37 °C. Quantification of the cryoprecipitate is performed measuring the total protein concentration using an in-house Lowry protein assay. Cryoprecipitate typing is performed with immunofixation electrophoresis on a hydrasys-2 device (Sebia, Evry, France). For evaluation of our adapted ‘3-day-protocol’ we performed a second cryoglobulin analysis next to our routine cryoglobulin analysis in a total of 14 different patients. For the ‘3-day-protocol’ the exact same procedure was performed as described above with the only exception that the blood was allowed to clot at 37 °C for 72 h, instead of 1–2 h.

Detection of cryoprecipitation: When the blood samples were stored at 37 °C for 72 h prior to serum collection, referred to as the ‘3-day-protocol’, all sera became hemolytic which was not observed when the routine protocol was applied (Figure 1A). When the sera were stored for at least three days at 4 °C, the hemolysis did not affect visual interpretation of the cryoprecipitate formation. Visual inspection of both results of all 14 patients performed by two independent technicians did not show discrepancies between both pre-analytical protocols in any of the samples. Seven samples were classified as negative by both methods and seven samples were classified as positive by both methods. The pre-analytical protocol also did not affect the cryoprecipitate washing procedure nor its capacity to dissolve again at 37 °C (data not shown).

Figure 1: 
Cryoglobulin analysis. (A) Five representative pictures taken of serum with a positive cryoglobulin obtained using our routine protocol (always left on picture) and using our ‘3-day-protocol’ (always right on picture). Hemolysis was observed in all sera obtained with the ‘3-day-protocol’ (average H-index 164). Approximately the same amount of cryoprecipitate was detected in both pre-analytical methods. (B) Immunofixation electrophoresis scans of one representative sample for each Brouet type is shown. The left scan shows the result when the routine pre-analytical protocol was used and the right scan shows the result when the ‘3-day-protocol’ was applied.
Figure 1:

Cryoglobulin analysis. (A) Five representative pictures taken of serum with a positive cryoglobulin obtained using our routine protocol (always left on picture) and using our ‘3-day-protocol’ (always right on picture). Hemolysis was observed in all sera obtained with the ‘3-day-protocol’ (average H-index 164). Approximately the same amount of cryoprecipitate was detected in both pre-analytical methods. (B) Immunofixation electrophoresis scans of one representative sample for each Brouet type is shown. The left scan shows the result when the routine pre-analytical protocol was used and the right scan shows the result when the ‘3-day-protocol’ was applied.

Cryo quantification: The washed crypreciptates have a whitish appearance in both pre-analytical protocols and no significant quantitative differences were observed (Table 1), indicating that the hemoglobulin and lysed erythrocytes do not end up in the washed cryoprecipitate. It must be noted however that quantification differences between both protocols is based on only seven positive samples. The small differences in cryoprecipitate concentration within individual patients are most likely caused by intra-assay variation of cryoprecipitate quantification since poor reproducibility of cryoglobulin quantification is a well described phenomenon [7].

Table 1:

Cryo-characteristics of seven positive samples.

Sample Brouet classification Cryo quantification, mg/L (routine) Cryo quantification, mg/L (‘day-3-protocol’)
Pt 7 Type I: IgM-K 108 161
Pt 8 Type II: IgM-K and poly IgM n.d. 133
Pt 9 Type I: IgG-K 3,564 3,258
Pt 10 Type III: poly IgM 83 58
Pt 11 Type II: IgM-L and poly IgG 137 143
Pt 12 Type II: IgM-K and poly IgG/IgM 65 69
Pt 13 Type II: IgM-K and poly IgG 164 207

Cryo typing: From the seven patients with a positive cryoglobulin result, the cryoprecipitates obtained with both the routine pre-analysis and the ‘3-day-protocol’ were all further processed for cryo typing using immunofixation electrophoresis. Independent interpretation of the results by two technicians resulted in 100 % identical Brouet classifications in all seven patients (Figure 1B). The quality of the cryoprecipitate washing step is amongst others assessed by looking at the background albumin band in the fixation-lane. Also in that aspect, no differences were observed between the two pre-analytical methods.

Drawing blood for cryoglobulin analysis is in most hospitals not feasible during weekends or bank holidays since pre-analysis requires specialized procedures that do not operate 24/7. A patient may therefore be asked to revisit the hospital for the sole purpose of undergoing a blood collection procedure for cryoglobulin analysis. In patients presenting to the emergency department during weekends with severe symptoms requiring immediate therapeutic intervention, obtaining a blood sample prior to the initiation of therapy may be hindered.

Here we showed that blood tubes drawn for cryoglobulin analysis could be stored and clotted at 37 °C for 72 h prior to serum separation in a pre-heated centrifuge. Although we observed signs of hemolysis in all samples that were measured with this ‘3-day protocol’, this did not affect the detection, immunotyping and quantification of cryoglobulins. The outcome of the data presented here, may facilitate simple and cost-effective solutions that allow drawing blood for cryoglobulin analysis during the weekend. For example, a plugged-in incubator [8] in the outpatient or emergency department allows stringent maintenance of pre-clotting temperature at 37 °C of blood samples obtained during the weekend. Directly after the weekend these blood samples can be collected and transported to the laboratory for further cryoglobulin analysis during office hours.


Corresponding author: Joannes F.M. Jacobs, PhD, MD, Department of Laboratory Medicine, Laboratory Medical Immunology, Radboud University Medical Center, (route 469), Geert Grooteplein 10, 6525 GA, Nijmegen, The Netherlands, E-mail: .

  1. Research ethics: This study was conducted in accordance with the Declaration of Helsinki (as revised in 2013) and was approved by the authors’ Institutional Review Board (#2016–2356).

  2. Informed consent: Informed consent was obtained from all individuals included in this study, or their legal guardians or wards.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: Not applicable.

References

1. Damoiseaux, J, Cohen Tervaert, JW. Diagnostics and treatment of cryoglobulinaemia: it takes two to tango. Clin Rev Allergy Immunol 2014;47:299–310. https://doi.org/10.1007/s12016-013-8390-y.Search in Google Scholar PubMed

2. Brouet, JC, Clauvel, JP, Danon, F, Klein, M, Seligmann, M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974;57:775–88. https://doi.org/10.1016/0002-9343-74-90852-3.Search in Google Scholar

3. Damoiseaux, J. The diagnosis and classification of the cryoglobulinemic syndrome. Autoimmun Rev 2014;13:359–62. https://doi.org/10.1016/j.autrev.2014.01.027.Search in Google Scholar PubMed

4. Kolopp-Sarda, MN, Miossec, P. Cryoglobulins: an update on detection, mechanisms and clinical contribution. Autoimmun Rev 2018;17:457–64. https://doi.org/10.1016/j.autrev.2017.11.035.Search in Google Scholar PubMed

5. Vermeersch, P, Gijbels, K, Marien, G, Lunn, R, Egner, W, White, P, et al.. A critical appraisal of current practice in the detection, analysis, and reporting of cryoglobulins. Clin Chem 2008;54:39–43. https://doi.org/10.1373/clinchem.2007.090134.Search in Google Scholar PubMed

6. Patel, D, Sargur, R, Sheldon, J, Wheeler, RD, Stanley, C. Evaluation of cryoprotein investigation using a digital external quality assurance scheme. Ann Clin Biochem 2024;61:347–55. https://doi.org/10.1177/00045632241239805.Search in Google Scholar PubMed

7. Sargur, R, White, P, Egner, W. Cryoglobulin evaluation: best practice? Ann Clin Biochem 2010;47:8–16. https://doi.org/10.1258/acb.2009.009180.Search in Google Scholar PubMed

8. Veerasubramanian, PK, Kabeerdoss, J, Sandhya, P, Devasahayam, S, Danda, D. Design and evaluation of cryodevice, an easy to use apparatus for maintenance of optimum temperature during cryoglobulin assay. Int J Rheum Dis 2018;21:230–2. https://doi.org/10.1111/1756-185x.13161.Search in Google Scholar

Received: 2025-07-08
Accepted: 2025-07-18
Published Online: 2025-07-08
Published in Print: 2025-11-25

© 2025 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. Challenging the dogma: why reviewers should be allowed to use AI tools
  4. Multivariate approaches to improve the interpretation of laboratory data
  5. Review
  6. Interference of therapeutic monoclonal antibodies with electrophoresis and immunofixation of serum proteins: state of knowledge and systematic review
  7. Opinion Papers
  8. Urgent call to the European Commission to simplify and contextualize IVDR Article 5.5 for tailored and precision diagnostics
  9. The importance of laboratory medicine in the management of CKD-MBD: insights from the KDIGO 2023 controversies conference
  10. Supplementation of pyridoxal-5′-phosphate in aminotransferase reagents: a matter of patient safety
  11. HCV serology: an unfinished agenda
  12. From metabolic profiles to clinical interpretation: multivariate approaches to population-based and personalized reference intervals and reference change values
  13. Genetics and Molecular Diagnostics
  14. A multiplex allele specific PCR capillary electrophoresis (mASPCR-CE) assay for simultaneously analysis of SMN1/SMN2/NAIP copy number and SMN1 loss-of-function variants
  15. General Clinical Chemistry and Laboratory Medicine
  16. From assessment to action: experience from a quality improvement initiative integrating indicator evaluation and adverse event analysis in a clinical laboratory
  17. Evaluation of measurement uncertainty of 11 serum proteins measured by immunoturbidimetric methods according to ISO/TS 20914: a 1-year laboratory data analysis
  18. Assessing the harmonization of current total vitamin B12 measurement methods: relevance and implications
  19. The current status of serum insulin measurements and the need for standardization
  20. Method comparison of plasma and CSF GFAP immunoassays across multiple platforms
  21. Cerebrospinal fluid leptin in Alzheimer’s disease: relationship to plasma levels and to cerebrospinal amyloid
  22. Verification of the T50 Calciprotein Crystallization test: bias estimation and interferences
  23. An innovative immunoassay for accurate aldosterone quantification: overcoming low-level inaccuracy and renal dysfunction-associated interference
  24. Oral salt loading combined with postural stimulation tests for confirming and subtyping primary aldosteronism
  25. Evaluating the performance of a multiparametric IgA assay for celiac disease diagnosis
  26. Clinical significance of anti-mitochondrial antibodies and PBC-specific anti-nuclear antibodies in evaluating atypical primary biliary cholangitis with normal alkaline phosphatase levels
  27. Reference Values and Biological Variations
  28. Establishment of region-, age- and sex-specific reference intervals for aldosterone and renin with sandwich chemiluminescence immunoassays
  29. Validation of a plasma GFAP immunoassay and establishment of age-related reference values: bridging analytical performance and routine implementation
  30. Comparative analysis of population-based and personalized reference intervals for biochemical markers in peri-menopausal women: population from the PALM cohort study
  31. Hematology and Coagulation
  32. Evaluation of stability and potential interference on the α-thalassaemia early eluting peak and immunochromatographic strip test for α-thalassaemia --SEA carrier screening
  33. Cardiovascular Diseases
  34. Analytical and clinical evaluation of an automated high-sensitivity cardiac troponin I assay for whole blood
  35. Diabetes
  36. Method comparison of diabetes mellitus associated autoantibodies in serum specimens
  37. Letters to the Editor
  38. Permitting disclosed AI assistance in peer review: parity, confidentiality, and recognition
  39. Response to the editorial by Karl Lackner
  40. Hemolysis detection using the GEM 7000 at the point of care in a pediatric hospital setting: does it affect outcomes?
  41. Estimation of measurement uncertainty for free drug concentrations using ultrafiltration
  42. Cryoglobulin pre-analysis over the weekend
  43. Accelerating time from result to clinical action: impact of an automated critical results reporting system
  44. Recent decline in patient serum folate test levels using Roche Diagnostics Folate III assay
  45. Kidney stones consisting of 1-methyluric acid
  46. Congress Abstracts
  47. 7th EFLM Conference on Preanalytical Phase
  48. Association of Clinical Biochemists in Ireland Annual Conference
  49. Association of Clinical Biochemists in Ireland Annual Conference
  50. 17th Congress of the Portuguese Society of Clinical Chemistry, Genetics and Laboratory Medicine
Downloaded on 29.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2025-0850/html
Scroll to top button